Vital Farms (VITL) 10-Q 7 Nov 24 2024 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 29, 2024	Nov. 04, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 29, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Registrant Name	Vital Farms, Inc.
Entity Central Index Key	0001579733
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Security 12b Title	Common Stock, par value $0.0001 per share
Trading Symbol	VITL
Security Exchange Name	NASDAQ
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-39411
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-0496985
Entity Address, Address Line One	3601 South Congress Avenue
Entity Address, Address Line Two	Suite C100
Entity Address, City or Town	Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78704
City Area Code	877
Local Phone Number	455-3063
Entity Common Stock, Shares Outstanding		43,789,647

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 149,534	$ 84,149
Investment securities, available-for-sale	13,480	32,667
Accounts receivable, net of allowance for credit losses of $559 and $550 as of September 29, 2024 and December 31, 2023, respectively	47,752	39,699
Inventories	33,392	32,895
Prepaid expenses and other current assets, net of allowance for credit losses of $192 and $227 as of September 29, 2024 and December 31, 2023, respectively	6,446	6,114
Income taxes receivable	990	0
Total current assets	251,594	195,524
Property, plant and equipment, net	69,269	66,839
Operating lease right-of-use assets	17,324	8,911
Goodwill and other assets	6,481	3,904
Total assets	344,668	275,178
Current liabilities:
Accounts payable	35,883	33,485
Accrued liabilities	33,345	24,218
Operating lease liabilities, current	4,665	3,057
Finance lease liabilities, current	3,852	3,255
Income taxes payable	0	1,206
Total current liabilities	77,745	65,221
Operating lease liabilities, non-current	3,675	5,771
Finance lease liabilities, non-current	9,023	10,481
Other liabilities	865	1,028
Total liabilities	91,308	82,501
Commitments and contingencies (Note 19)
Stockholders’ equity:
Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized as of September 29, 2024 and December 31, 2023; no shares issued and outstanding as of September 29, 2024 and December 31, 2023	0	0
Common stock, $0.0001 par value per share, 310,000,000 shares authorized as of September 29, 2024 and December 31, 2023; 43,705,476 and 41,684,649 shares issued and outstanding as of September 29, 2024 and December 31, 2023, respectively	4	4
Additional paid-in capital	180,887	163,325
Retained earnings	72,533	29,725
Accumulated other comprehensive loss	(64)	(377)
Total stockholders’ equity	253,360	192,677
Total liabilities and stockholders' equity	$ 344,668	$ 275,178

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts Receivable, net of allowance for credit losses	$ 559	$ 550
Prepaid expenses and other current assets, net of allowance for credit losses	$ 192	$ 227
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	310,000,000	310,000,000
Common stock, shares issued	43,705,476	41,684,649
Common stock, shares outstanding	43,705,476	41,684,649

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Income Statement [Abstract]
Net revenue	$ 145,002	$ 110,429	$ 440,318	$ 336,046
Cost of goods sold	91,526	73,764	270,268	218,913
Gross profit	53,476	36,665	170,050	117,133
Operating expenses:
Selling, general and administrative	36,102	25,081	96,569	72,935
Shipping and distribution	8,134	6,355	22,933	20,034
Total operating expenses	44,236	31,436	119,502	92,969
Income from operations	9,240	5,229	50,548	24,164
Other income (expense), net:
Interest expense	(259)	(238)	(771)	(513)
Interest income	1,407	707	3,811	1,497
Other expense, net	(6)	(642)	(370)	(2,508)
Total other income (expense), net	1,142	(173)	2,670	(1,524)
Net income before income taxes	10,382	5,056	53,218	22,640
Income tax provision	2,936	533	10,410	4,284
Net income	$ 7,446	$ 4,523	$ 42,808	$ 18,356
Net income per share:
Basic:	$ 0.17	$ 0.11	$ 1.01	$ 0.45
Diluted:	$ 0.16	$ 0.1	$ 0.95	$ 0.42
Weighted average common shares outstanding:
Basic:	43,249,234	41,375,008	42,517,088	41,037,778
Diluted:	45,463,862	43,135,579	44,923,684	43,299,898

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 7,446	$ 4,523	$ 42,808	$ 18,356
Other comprehensive income, before tax:
Unrealized net holding gain	138	271	416	916
Amounts reclassified for realized gains (losses) to earnings	0	53	(1)	182
Available-for-sale debt securities, before tax	138	324	415	1,098
Other comprehensive income, before tax	138	324	415	1,098
Income tax expense related to items of other comprehensive income	(34)	(85)	(102)	(276)
Other comprehensive income, net of tax	104	239	313	822
Comprehensive income	$ 7,550	$ 4,762	$ 43,121	$ 19,178

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY(Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 25, 2022	$ 158,332	$ 4	$ 155,716	$ 4,159	$ (1,547)
Beginning Balance, Shares at Dec. 25, 2022		40,746,990
Vesting of restricted stock units, Shares		127,595
Shares withheld for tax liability on vested restricted stock units, Shares		(35,535)
Stock-based compensation expense	1,627		1,627
Other comprehensive income loss, net	421				421
Net income	7,150			7,150
Ending Balance at Mar. 26, 2023	167,530	$ 4	157,343	11,309	(1,126)
Ending Balance, Shares at Mar. 26, 2023		40,839,050
Beginning Balance at Dec. 25, 2022	158,332	$ 4	155,716	4,159	(1,547)
Beginning Balance, Shares at Dec. 25, 2022		40,746,990
Other comprehensive income loss, net	822
Ending Balance at Sep. 24, 2023	182,875	$ 4	161,081	22,515	(725)
Ending Balance, Shares at Sep. 24, 2023		41,574,449
Beginning Balance at Mar. 26, 2023	167,530	$ 4	157,343	11,309	(1,126)
Beginning Balance, Shares at Mar. 26, 2023		40,839,050
Exercise of stock options	110		110
Exercise of stock options, Shares		307,500
Vesting of restricted stock units, Shares		79,030
Shares withheld for tax liability on vested restricted stock units	(636)		(636)
Shares withheld for tax liability on vested restricted stock units, Shares		(3,924)
Stock Issued During Period, Shares, Employee Stock Purchase Plans		11,011
Stock Issued During Period, Value, Employee Stock Purchase Plan	135		135
Stock-based compensation expense	2,060		2,060
Other comprehensive income loss, net	162				162
Net income	6,683			6,683
Ending Balance at Jun. 25, 2023	176,044	$ 4	159,012	17,992	(964)
Ending Balance, Shares at Jun. 25, 2023		41,232,667
Exercise of stock options	286		286
Exercise of stock options, Shares		335,000
Vesting of restricted stock units, Shares		9,525
Shares withheld for tax liability on vested restricted stock units	(32)		(32)
Shares withheld for tax liability on vested restricted stock units, Shares		(2,743)
Stock-based compensation expense	1,815		1,815
Other comprehensive income loss, net	239				239
Net income	4,523			4,523
Ending Balance at Sep. 24, 2023	182,875	$ 4	161,081	22,515	(725)
Ending Balance, Shares at Sep. 24, 2023		41,574,449
Beginning Balance at Dec. 31, 2023	$ 192,677	$ 4	163,325	29,725	(377)
Beginning Balance, Shares at Dec. 31, 2023	41,684,649	41,684,649
Exercise of stock options	$ 824		824
Exercise of stock options, Shares		180,086
Vesting of restricted stock units, Shares		201,702
Shares withheld for tax liability on vested restricted stock units	(1,310)		(1,310)
Shares withheld for tax liability on vested restricted stock units, Shares		(62,781)
Stock-based compensation expense	1,982		1,982
Other comprehensive income loss, net	108				108
Net income	19,023			19,023
Ending Balance at Mar. 31, 2024	213,304	$ 4	164,821	48,748	(269)
Ending Balance, Shares at Mar. 31, 2024		42,003,656
Beginning Balance at Dec. 31, 2023	$ 192,677	$ 4	163,325	29,725	(377)
Beginning Balance, Shares at Dec. 31, 2023	41,684,649	41,684,649
Exercise of stock options, Shares	1,818,001
Other comprehensive income loss, net	$ 313
Ending Balance at Sep. 29, 2024	$ 253,360	$ 4	180,887	72,533	(64)
Ending Balance, Shares at Sep. 29, 2024	43,705,476	43,705,476
Beginning Balance at Mar. 31, 2024	$ 213,304	$ 4	164,821	48,748	(269)
Beginning Balance, Shares at Mar. 31, 2024		42,003,656
Exercise of stock options	5,624		5,624
Exercise of stock options, Shares		911,605
Vesting of restricted stock units, Shares		41,316
Shares withheld for tax liability on vested restricted stock units	(41)		(41)
Shares withheld for tax liability on vested restricted stock units, Shares		(1,432)
Stock Issued During Period, Shares, Employee Stock Purchase Plans		16,843
Stock Issued During Period, Value, Employee Stock Purchase Plan	178		178
Stock-based compensation expense	2,916		2,916
Other comprehensive income loss, net	101				101
Net income	16,339			16,339
Ending Balance at Jun. 30, 2024	238,421	$ 4	173,498	65,087	(168)
Ending Balance, Shares at Jun. 30, 2024		42,971,988
Exercise of stock options	4,857		4,857
Exercise of stock options, Shares		726,310
Vesting of restricted stock units, Shares		10,693
Shares withheld for tax liability on vested restricted stock units	(142)		(142)
Shares withheld for tax liability on vested restricted stock units, Shares		(3,515)
Stock-based compensation expense	2,674		2,674
Other comprehensive income loss, net	104				104
Net income	7,446			7,446
Ending Balance at Sep. 29, 2024	$ 253,360	$ 4	$ 180,887	$ 72,533	$ (64)
Ending Balance, Shares at Sep. 29, 2024	43,705,476	43,705,476

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023
Cash flows from operating activities:
Net income	$ 42,808	$ 18,356
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	6,978	5,595
Reduction in the carrying amount of right-of-use assets	5,644	2,787
Amortization of available-for-sale debt securities	96	341
Amortization of debt issuance costs	39	0
Stock-based compensation expense	7,572	5,502
Deferred taxes	(267)	1,082
Unrealized loss on derivative instruments	394	761
Other	926	363
Net change in operating assets and liabilities	(14,147)	(7,610)
Net cash provided by operating activities	50,043	27,177
Cash flows from investing activities:
Purchases of property, plant and equipment	(10,482)	(9,138)
Purchases of available-for-sale debt securities	0	(982)
Purchases and settlements of derivative instruments	(669)	(1,264)
Sales of available-for-sale debt securities	0	2,895
Maturities and call redemptions of available-for-sale debt securities	19,505	25,228
Proceeds from the sale of property, plant and equipment	1	1,056
Return of investment in variable interest entity	0	552
Net cash provided by investing activities	8,355	18,347
Cash flows from financing activities:
Proceeds from exercise of stock options	11,305	396
Proceeds from issuance of common stock under employee stock purchase plan	178	135
Payment of tax withholding obligation on vested restricted stock unit shares	(1,493)	(668)
Principal payments under finance lease obligations	(2,589)	(1,491)
Payment of financing costs	(414)	0
Net cash provided by (used in) financing activities	6,987	(1,628)
Net increase in cash and cash equivalents	65,385	43,896
Cash and cash equivalents at beginning of the period	84,149	12,914
Cash and cash equivalents at end of the period	149,534	56,810
Supplemental disclosure of cash flow information:
Cash paid for interest	732	507
Cash paid for income taxes	12,873	3,189
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property, plant and equipment included in accounts payable and accrued liabilities	433	667
Revolving Line of Credit
Cash flows from financing activities:
Proceeds from borrowing under revolving line of credit	0	7,500
Repayment of revolving line of credit	$ 0	$ (7,500)

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Sep. 29, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 24, 2023	Jun. 25, 2023	Mar. 26, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 7,446	$ 16,339	$ 19,023	$ 4,523	$ 6,683	$ 7,150

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 29, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Director and Officer Trading Arrangements During the 13-week period ended September 29, 2024, certain of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, as set forth in the table below: Type of Trading Arrangement Name and Position Action Adoption/ Termination Date Rule 10b5-1* Non-Rule 10b5-1** Total Shares of Common Stock to be Sold Total Shares of Common Stock to be Purchased Expiration Date Joanne Bal , General Counsel, Corporate Secretary and Head of Impact Adoption August 14, 2024 X 84,739 May 30, 2025 * Contract, instructions, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. ** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
Name	Joanne Bal
Title	General Counsel, Corporate Secretary and Head of Impact
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 14, 2024
Expiration Date	May 30, 2025
Arrangement Duration	289 days
Aggregate Available	84,739

Nature of the Business and Basi

Nature of the Business and Basis of Presentation	9 Months Ended
	Sep. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of the Business and Basis of Presentation	Note 1. Nature of the Business and Basis of Presentation Vital Farms, Inc. (the “Company”) was incorporated in Delaware on June 6, 2013 and is headquartered in Austin, Texas. The Company packages, markets and distributes shell eggs, butter and other products. These products are principally sold under the name Vital Farms in addition to other trade names, primarily to retail and foodservice channels in the United States. The accompanying unaudited condensed consolidated financial statements as of September 29, 2024 and for the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023 have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Annual Report”). In the opinion of management, the included disclosures are adequate, and the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary for a fair statement of the Company’s consolidated financial position as of September 29, 2024, consolidated results of operations for the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023, and consolidated cash flows for the 39-week periods ended September 29, 2024 and September 24, 2023. Such adjustments are of a normal and recurring nature and certain reclassifications of previously reported amounts have been made to conform to the current year presentation. The condensed consolidated balance sheet as of December 31, 2023 was derived from audited annual financial statements but does not contain all of the footnote disclosures from the audited annual financial statements. The condensed consolidated results of operations for the 13-week and 39-week periods ended September 29, 2024 are not necessarily indicative of the consolidated results of operations that may be expected for the fiscal year ending December 29, 2024. Fiscal Year: The Company’s fiscal year ends on the last Sunday in December and contains either 52 or 53 weeks. In a 52-week fiscal year, each of the Company’s fiscal quarters consist of 13 weeks. The additional week in a 53-week fiscal year is added to the fourth quarter, making such quarter consist of 14 weeks. Therefore, the financial results of certain 53-week fiscal years, and the associated 14-week quarters, will not be exactly comparable to the prior and subsequent 52-week fiscal years and the associated 13-week quarters. The fiscal quarters ended September 29, 2024 and September 24, 2023 both contain operating results for 13 weeks. The fiscal year ended December 31, 2023 consisted of 53 weeks.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 29, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The significant accounting policies and estimates used in preparation of the unaudited condensed consolidated financial statements are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 31, 2023, and the notes thereto, which are included in the Annual Report. Other than the adoption of the new accounting pronouncements and standards as further described below, there have been no material changes to the Company’s significant accounting policies during the 39-week period ended September 29, 2024. Recently Adopted Accounting Pronouncements The new accounting pronouncements recently adopted by the Company are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 31, 2023, and the notes thereto, which are included in the Annual Report. There have been no new accounting pronouncements adopted by the Company during the 39-week period ended September 29, 2024. Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU 2023-07, Segment Reporting (Topic 280) — Improvements to Reportable Segment Disclosures (“ASU 2023-07”) in order to improve stockholders’ understanding of an entity’s business activities through enhanced disclosures around reportable segments. ASU 2023-07 will require incremental and more detailed disclosure regarding segment expenses on both an annual and interim basis. For public companies ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company plans to adopt the standard for the year ended December 29, 2024 and will thus include any additional disclosures in its Annual Report on Form 10-K for the current fiscal year. In December 2023, the FASB issued ASU No 2023-09, Income Taxes (Topic 740) — Improvements to Income Tax Disclosures (“ASU 2023-09”) in order to enhance the transparency and usefulness of income tax disclosures. The guidance is applicable to all entities subject to income tax and it will require disclosure of certain categories within the rate reconciliation to improve consistency as well as disclosure of reconciling items which meet a certain quantitative threshold which will improve transparency. Additionally, entities must disclose the amount of taxes paid to federal, state and foreign municipalities. For public companies, ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company expects to adopt the standard for the fiscal year beginning December 30, 2024. The Company is currently evaluating the impact of its pending adoption of ASU 2023-09 on its consolidated financial statements.

Investment Securities

Investment Securities	9 Months Ended
	Sep. 29, 2024
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Note 3. Investment Securities The following table summarizes the Company’s available-for-sale investment securities as of September 29, 2024: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value U.S. corporate bonds and U.S. dollar $ 13,531 $ 17 $ ( 68 ) $ — $ 13,480 Total $ 13,531 $ 17 $ ( 68 ) $ — $ 13,480 The following table summarizes the Company’s available-for-sale investment securities as of December 31, 2023: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value U.S. corporate bonds and U.S. dollar $ 33,134 $ 10 $ ( 477 ) $ — $ 32,667 Total $ 33,134 $ 10 $ ( 477 ) $ — $ 32,667 Proceeds from the sale of available-for-sale securities were $ 0 for the 13-week and 39-week periods ended September 29, 2024 and $ 988 and $ 2,895 for the 13-week and 39-week periods ended September 24, 2023. Actual maturities may differ from contractual maturities because some borrowers have the right to call or prepay obligations with or without call or prepayment penalties. The amortized cost and fair value of the Company’s investments in available-for-sale securities as of September 29, 2024 by contractual maturity are as follows: Amortized Cost Fair Value Due within one year $ 12,518 $ 12,456 Due after one year through five years 1,013 1,024 Total available-for-sale $ 13,531 $ 13,480 The following tables present the Company ’s unrealized loss aging for available-for-sale securities by type and length of time the security was in a continuous unrealized loss position as of the periods presented: September 29, 2024 Less than 12 months 12 months or longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. corporate bonds and U.S. dollar $ - $ - $ 11,801 $ ( 68 ) $ 11,801 $ ( 68 ) Total $ - $ - $ 11,801 $ ( 68 ) $ 11,801 $ ( 68 ) December 31, 2023 Less than 12 months 12 months or longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. corporate bonds and U.S. dollar $ 699 $ ( 3 ) $ 29,247 $ ( 474 ) $ 29,946 $ ( 477 ) Total $ 699 $ ( 3 ) $ 29,247 $ ( 474 ) $ 29,946 $ ( 477 ) As of September 29, 2024 , there were 17 diversified issuances in the Company ’ s securities portfolio in an unrealized loss position, with credit ratings ranging from BBB- to AA-. As of September 29, 2024, there are no individual bonds with unrealized losses exceeding $ 8 , and 17 issuances have been in a loss position greater than 12 months. The decline in fair value has resulted primarily from rising interest rates over the last 12 months, and the Company does not believe there has been any significant decline in the creditworthiness of the issuers. The Company also does not believe it is likely that a significant number of bonds will be called early, and it does not have current liquidity needs that would necessitate a sale of any material investments prior to maturity. Therefore, the Company has no t recorded an allowance for credit losses on the investment securities as of September 29, 2024. The fair value and location of all investment securities are included in “Fair Value Measurements” in Note 5 below.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Note 4. Derivative Financial Instruments The Company enters into derivative instruments to mitigate the impact of commodity price volatility. Such instruments may include call options on commodity price contracts. Realized and unrealized gains and losses on the Company’s commodity derivatives not designated as hedging instruments are recorded in other expense, net. The Company recognizes all derivative instruments as either assets or liabilities. The following table presents the aggregated outstanding notional amounts related to the Company’s derivative financial instruments for the periods presented: Metric September 29, December 31, Commodity: Corn Bushels (in thousands) 860 2,351 Soybean Meal Tons — 25 For the 13-week periods ended September 29, 2024 and September 24, 2023, the pre-tax amount of commodity contract derivative losses recognized in other expense, net was $ 6 and $ 588 , respectively. For the 39-week periods ended September 29, 2024 and September 24, 2023, the pre-tax amount of commodity contract derivative losses recognized in other expense, net was $ 393 and $ 2,405 , respectively. The fair value and location of all outstanding derivative financial instruments are included in “Fair Value Measurements” in Note 5 below.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 29, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 5. Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels of inputs that may be used to measure fair value are defined below: • Level 1 – Quoted prices in active markets for identical assets or liabilities. • Level 2 – Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 – Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. Assets Measured at Fair Value on a Recurring Basis The fair value hierarchy requires the use of observable market data when available. In instances where the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement has been determined based on the lowest level input significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. The following tables present information about the Company’s financial assets measured at fair value on a recurring basis for the periods presented: Fair Value Measurements as of September 29, 2024, Using: Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market $ 109,157 $ — $ — $ 109,157 Investment securities, available-for-sale: U.S. corporate bonds and U.S. dollar — 13,480 — 13,480 Total assets measured at fair value $ 109,157 $ 13,480 $ — $ 122,637 Fair Value Measurements as of December 31, 2023, Using: Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market $ 64,498 $ — $ — $ 64,498 Investment securities, available-for-sale: U.S. corporate bonds and U.S. dollar — 32,667 — 32,667 Derivative financial instruments — 394 — 394 Total assets measured at fair value $ 64,498 $ 33,061 $ — $ 97,559 During the 39-week period ended September 29, 2024 , there were no transfers between fair value measurement levels. For additional information on concentrations of credit risk for the Company ’s financial instruments, refer to “Investment Securities” in Note 3 above. Fair Value of Other Financial Instruments The carrying values of the Company’s short-term financial instruments not included above, including cash, trade receivables, other receivables and accounts payable, approximate their fair value due to their short-term nature.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 29, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Note 6. Revenue Recognition The following table summarizes the Company’s net revenue by primary product for the periods presented: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Net Revenue: Eggs and egg-related products $ 138,142 $ 103,887 $ 424,863 $ 318,462 Butter and butter-related products 6,860 6,542 15,455 17,584 Net Revenue $ 145,002 $ 110,429 $ 440,318 $ 336,046 Net revenue is primarily generated from the sale of eggs and butter. The Company’s product offerings include shell eggs, hard-boiled eggs, liquid whole eggs and stick butter. The Company’s previous convenient breakfast product line (including egg bites and egg-based breakfast bars) was discontinued in 2022, and the Company’s ghee and spreadable tub butter product offerings were discontinued in 2023. The revenues related to the discontinued product lines were immaterial for the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023. During the 13-week periods ended September 29, 2024 and September 24, 2023 and 39-week periods ended September 29, 2024 and September 24, 2023 , the Company had customers that individually exceeded 10% or more of the Company’s net revenue. The percentage of net revenue from significant customers during the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023 is as follows: Net Revenue Net Revenue Net Revenue Net Revenue Customer A 24 % 24 % 24 % 25 % Customer B 10 % * 10 % * * Net revenue was less than 10% As of September 29, 2024 and December 31, 2023 , the Company had customers that individually exceeded 10% or more of the Company’s accounts receivable. The percentage of accounts receivable, net due from significant customers as of September 29, 2024 and December 31, 2023 is as follows: Accounts Receivable, Net as of September 29, 2024 Accounts Receivable, Net as of December 31, 2023 Customer A 14 % 18 % Customer B 10 % 12 % Customer C * 11 % Customer D 10 % 11 % Customer E 14 % * * Accounts receivable, net was less than 10%

Allowance for Credit Losses

Allowance for Credit Losses	9 Months Ended
	Sep. 29, 2024
Allowance for Credit Loss [Abstract]
Allowance for Credit Losses	Note 7. Allowance for Credit Losses As of September 29, 2024 and December 31, 2023, the Company had an allowance for credit losses of $ 751 and $ 777 , respectively. The Company recognizes current estimated credit losses (“CECL”) for accounts receivable and other receivables. The CECL for trade receivables are estimated based on the trade receivable aging category, credit risk of specific customers, past collection history, and management’s evaluation of accounts receivable. The Company also has other receivables which are classified within prepaid expenses and other current assets. The CECL for other receivables are estimated based on the other receivables aging category and the probability of default. Provisions for CECL are classified within selling, general and administrative costs Changes in the allowance for credit losses for the 39-week period ended September 29, 2024 were as follows: Accounts Receivable Prepaid Expenses and other Current Assets Total As of December 31, 2023 $ ( 550 ) $ ( 227 ) $ ( 777 ) Reductions (provisions) charged to operating results 284 ( 48 ) 236 Account write-offs — 140 140 As of March 31, 2024 $ ( 266 ) $ ( 135 ) $ ( 401 ) (Provisions) reductions charged to operating results ( 248 ) 18 ( 230 ) Account write-offs — — — As of June 30, 2024 $ ( 514 ) $ ( 117 ) $ ( 631 ) (Provisions) reductions charged to operating results ( 45 ) ( 75 ) ( 120 ) Account write-offs — — — As of September 29, 2024 $ ( 559 ) $ ( 192 ) $ ( 751 )

Inventories

Inventories	9 Months Ended
	Sep. 29, 2024
Inventory Disclosure [Abstract]
Inventories	Note 8. Inventories Inventory consisted of the following as of the periods presented: September 29, December 31, Eggs and egg-related products $ 18,980 $ 25,521 Butter and butter-related products 8,344 1,697 Packaging 4,158 4,988 Pullets 847 289 Other 1,236 896 Reserve for inventory obsolescence ( 173 ) ( 496 ) Inventories $ 33,392 $ 32,895 On a periodic basis, the Company compares the amount of inventory on hand with its latest forecasted requirements to determine whether provisions for excess or obsolete inventory reserves are required.

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
	Sep. 29, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Note 9. Property, Plant and Equipment Property, plant and equipment consisted of the following as of the periods presented: September 29, December 31, Land $ 6,549 $ 552 Land improvements 818 818 Buildings and improvements 30,502 30,532 Vehicles 1,179 1,055 Machinery and equipment 56,672 50,979 Leasehold improvements 491 492 Furniture and fixtures 535 461 Construction in progress 3,216 3,001 99,962 87,890 Less: Accumulated depreciation and amortization ( 30,693 ) ( 21,051 ) Property, plant and equipment, net $ 69,269 $ 66,839 During the 13-week periods ended September 29, 2024 and September 24, 2023, depreciation of property, plant and equipment was approximately $ 2,331 and $ 2,052 , respectively. During the 39-week periods ended September 29, 2024 and September 24, 2023, depreciation of property, plant and equipment was approximately $ 6,978 and $ 5,595 , respectively.

Leases

Leases	9 Months Ended
	Sep. 29, 2024
Leases [Abstract]
Leases	Note 10. Leases Operating lease cost is recognized on a straight-line basis over the lease term and finance lease cost is recognized as amortization expense for the right-of-use (“ROU”) assets and interest expense associated with the finance lease liabilities. The components of lease cost, classified within cost of goods sold, selling, general and administrative and interest expense for the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023 are below: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Operating lease cost $ 1,271 $ 411 $ 3,255 $ 1,133 Finance lease cost – amortization of ROU assets 999 808 $ 2,851 1,702 Finance lease cost – interest on lease liabilities 238 238 $ 723 495 Short-term lease cost 39 316 $ 107 738 Variable lease cost 2,971 973 $ 8,073 4,651 Variable lease cost – long-term supply contracts 54,496 48,453 $ 164,928 138,603 Total lease cost $ 60,014 $ 51,199 $ 179,937 $ 147,322 Future undiscounted cash flows are as follows: As of September 29, 2024 Operating Leases Finance Leases 2024 $ 2,430 $ 1,150 2025 3,434 4,633 2026 3,018 4,670 2027 — 3,850 Total lease payments 8,882 14,303 Less imputed interest ( 542 ) ( 1,428 ) Total present value of lease liabilities $ 8,340 $ 12,875 During the 39-week periods ended September 29, 2024 and September 24, 2023, ROU assets obtained in exchange for new finance lease obligations were $ 1,753 and $ 7,132 , respectively. During the 39-week periods ended September 29, 2024 and September 24, 2023, ROU assets obtained in exchange for new operating lease obligations were $ 11,203 and $ 703 , respectively.

Goodwill and Other Assets

Goodwill and Other Assets	9 Months Ended
	Sep. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Assets	Note 11. Goodwill and Other Assets Goodwill and other assets consisted of the following as of the periods presented: September 29, December 31, Goodwill $ 3,858 $ 3,858 Software development costs 2,577 — Other non-current assets 46 46 Goodwill and other assets $ 6,481 $ 3,904 As of September 29, 2024 , the Company has capitalized costs of $ 2,577 relating to cloud computing arrangement implementation costs. This software has been developed by third-party and internal labor and has passed the preliminary project stage prior to capitalization. Amortization of the cloud computing arrangement implementation costs will begin once the software is placed in service.

Accrued Liabilities

Accrued Liabilities	9 Months Ended
	Sep. 29, 2024
Payables and Accruals [Abstract]
Accrued Liabilities	Note 12. Accrued Liabilities Accrued liabilities consisted of the following as of the periods presented: September 29, December 31, Employee-related costs $ 15,349 $ 9,131 Promotions and customer deductions 8,787 6,982 Distribution fees and freight 2,427 2,876 Marketing and broker commissions 3,374 3,627 Purchases of inventory 1,648 525 Professional fees 1,338 1,066 Other 422 11 Accrued liabilities $ 33,345 $ 24,218

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 29, 2024
Debt Disclosure [Abstract]
Long-Term Debt	Note 13. Long-Term Debt PNC Credit Facility In October 2017, the Company entered into a credit facility agreement with PNC Bank, National Association (the “PNC Credit Facility”), which was modified at various times between fiscal 2018 and fiscal 2023. Such amendments included (i) amendments to various definitions and covenants, (ii) waiver of a technical default in May 2020, (iii) increased borrowing capacity, (iv) elimination of a term loan and equipment loan, and (v) extension of the maturity date. The PNC Credit Facility was terminated on April 9, 2024 when the Company entered into a syndicated credit agreement with JPMorgan Chase Bank, N.A. and the other lenders party thereto (the “JPMorgan Credit Facility”). The maximum borrowing capacity under the PNC Credit Facility ’ s revolving line of credit was $ 20.0 million. Interest on borrowings under the revolving line of credit, as well as loan advances thereunder, accrued at a rate, at the Company’s election at the time of borrowing, equal to (i) the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York plus 2.00 % or (ii) 1.00 % plus the alternate base rate, as defined in the PNC Credit Facility. The PNC Credit Facility was secured by all of the Company’s assets (other than real property and certain other property excluded pursuant to the terms of the PNC Credit Facility) and required the Company to maintain three financial covenants: a fixed charge coverage ratio, a leverage ratio and a minimum tangible net worth requirement. The PNC Credit Facility also contained various covenants relating to limitations on indebtedness, acquisitions, mergers, consolidations and the sale of properties and liens. The PNC Credit Facility also contained other customary covenants, representations and events of default. JPMorgan Credit Facility On April 9, 2024, the Company entered into the JPMorgan Credit Facility, which provides for a five-year, $ 60.0 million revolving credit facility. The JPMorgan Credit Facility includes a $ 5.0 million letter of credit sub-limit and an accordion option that would allow the Company to increase the aggregate revolving commitments or add incremental term loans in an aggregate amount not to exceed the greater of (i) $ 35.0 million and (ii) an amount equal to 100 % of consolidated adjusted EBITDA. Any borrowings under the JPMorgan Credit Facility bear interest, at the Company ’ s election, at either (i) an adjusted term Secured Overnight Financing Rate or adjusted daily Secured Overnight Financing Rate plus 0.10 % plus a margin of either 0.75%, 1.00% or 1.25% depending on the Company ’s net leverage ratio or (ii) an alternative base rate plus a margin or either 1.75%, 2.00% or 2.25%, depending on the Company’s net leverage ratio. The Company is required to pay a commitment fee on the undrawn portion of the aggregate commitments that accrues at either 0.20% or 0.375% per annum depending on the Company’ s revolving exposure. Additionally, the Company is required to pay a participation fee on the account of each lender for each outstanding letter of credit at a rate equal to the applicable rate used to determine the interest rate applicable to term benchmark revolving loans. The JPMorgan Credit Facility is secured by liens on substantially all of the Company’ s assets, including certain intellectual property assets and investment securities. It requires the Company to maintain (i) a net leverage ratio of no greater than 3.25 to 1.00, subject to two increases up to 4.00 to 1.00 for a certain period following material acquisitions, and (ii) a fixed charge coverage ratio of no less than 1.35 to 1.00. As a result of the limitations contained in the JPMorgan Credit Facility, certain of the net assets on the Company’s consolidated balance sheet as of September 29, 2024 are restricted in use. The Company’s wholly owned subsidiaries are non-operating and have no restricted net assets within the meaning of Rule 4-08(e)(3) or Rule 12-04 of Regulation S-X. As of September 29, 2024, the Company was in compliance with all covenants under the JPMorgan Credit Facility. As of September 29, 2024 , there were no outstanding amounts under the JPMorgan Credit Facility. During the 13-week periods ended September 29, 2024 and September 24, 2023 , the Company recognized no interest expense related to draws on our revolving lines of credit. During the 39-week periods ended September 29, 2024 and September 24, 2023, the Company recognized interest expense related to draws on our revolving lines of credit of $ 0 and $ 7 , respectively.

Common Stock

Common Stock	9 Months Ended
	Sep. 29, 2024
Equity [Abstract]
Common Stock	Note 14. Common Stock As of September 29, 2024 , the Company’s amended and restated certificate of incorporation authorized the Company to issue 310,000,000 shares of common stock, par value $ 0.0001 per share, of which 43,705,476 shares were issued and outstanding. The voting, dividend and liquidation rights of the holders of the Company’s common stock are subject to and qualified by the rights, powers and preferences of the holders of the preferred stock, if any. Each share of the Company’s common stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders. Holders of the Company’s common stock are entitled to receive dividends as may be declared by the Company’s Board of Directors (the “Board of Directors” ), if any, subject to the preferential dividend rights of preferred stock, if any. No cash dividends were declared or paid during the periods presented. As of each balance sheet date, the Company had reserved shares of common stock for issuance in connection with the following: September 29, December 31, Options to purchase common stock 2,043,194 3,920,485 Restricted stock units (“RSUs”) 649,956 565,376 Performance stock units (“PSUs”) 238,704 — Shares available for grant under the 2020 Equity Incentive 14,964,423 13,313,326 Total 17,896,277 17,799,187

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 29, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 15. Stock-Based Compensation The Company measures compensation expense for all stock-based awards based on the estimated fair values on the date of the grant. Stock options generally vest ratably over three years from the date of grant, subject to the recipient’s continued service over such period, and expire 10 years from the date of grant. RSUs generally vest ratably over three years from the date of grant, subject to the recipient’s continued service over such period, and contain no other service or performance conditions. PSUs vest at the end of a three-year period based on the achievement of certain Company performance metrics and the recipient’s continued service over such period. The Company’s policy is to recognize stock-based compensation expense on a straight-line basis over the requisite service or vesting period. For awards that are contingent upon performance metrics, the probability of achievement is taken into account in the calculation of the expense to be recognized and modified as needed. Forfeitures for stock options and restricted stock awards, including RSUs and PSUs, are recognized as they occur. The Company recognized stock-based compensation expense in the condensed consolidated statements of operations for the periods presented: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Cost of goods sold $ 72 $ 61 $ 226 $ 194 Selling, general and administrative expense 2,602 1,754 7,346 5,308 Total $ 2,674 $ 1,815 $ 7,572 $ 5,502 Stock Option Activity The following table summarizes the Company’s stock option activity since December 31, 2023: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2023 3,920,485 $ 10.07 $ 28,749 Granted — $ — Exercised ( 1,818,001 ) $ 6.22 $ 47,872 Cancelled/Forfeited ( 59,290 ) $ 22.59 $ 225 Outstanding as of September 29, 2024 2,043,194 $ 13.13 5.4 $ 44,959 Options exercisable as of September 29, 2024 1,630,749 $ 12.47 4.9 $ 36,949 Options vested and expected to vest as of September 29, 2024 2,043,194 $ 13.13 5.4 $ 44,959 The fair value of stock options vested during the 13-week periods ended September 29, 2024 and September 24, 2023 was $ 1,065 and $ 1,633 , respectively. The fair value of stock options vested during the 39-week periods ended September 29, 2024 and September 24, 2023 was $ 2,965 and $ 2,905 , respectively. As of September 29, 2024, total unrecognized stock-based compensation expense related to unvested stock options was $ 1,347 , which is expected to be recognized over a weighted-average period of 1.37 years. Restricted Stock Unit Activity The following table summarizes the Company’s RSU activity since December 31, 2023: Number of Weighted- Unvested as of December 31, 2023 565,376 $ 14.24 Granted 415,014 $ 22.46 Vested 1 ( 253,711 ) $ 14.40 Forfeited ( 76,723 ) $ 16.89 Unvested as of September 29, 2024 649,956 $ 19.12 1 Includes 67,728 shares of common stock withheld to cover taxes on the release of vested RSUs, which became available for future grants pursuant to the 2020 Equity Incentive Plan. The fair value of RSU shares vested during the 13-week periods ended September 29, 2024 and September 24, 2023 was $ 75 and $ 113 , respectively. The fair value of RSU shares vested during the 39-week periods ended September 29, 2024 and September 24, 2023 was $ 3,655 and $ 3,026 , respectively. As of September 29, 2024, total unrecognized stock-based compensation expense related to the RSUs was $ 9,484 , which is expected to be recognized over a weighted-average period of 2.09 years. Performance Stock Unit Activity In fiscal year 2024, the Company granted PSUs to certain of its officers and other employees. These PSUs vest at the end of a three-year period dependent upon the level of achievement of certain Company performance metrics and the recipient’s continued service over such period. The number of shares that can be earned will range from 0 % to 200 % of the granted PSUs, based upon the Company’s level of achievement of the stated performance metrics. The number of PSUs expected to vest and for which compensation cost has been recognized is based on the number of awards that the Company believes are probable to vest as of September 29, 2024. The following table summarizes the Company’s PSU activity since December 31, 2023: Number of Weighted- Unvested as of December 31, 2023 — $ — Granted 255,019 $ 21.73 Forfeited ( 16,315 ) $ 20.99 Unvested as of September 29, 2024 238,704 $ 21.78 The fair value of PSU shares vested during the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023 was $ 0 as no shares have vested as of such periods. As of September 29, 2024, total unrecognized stock-based compensation expense related to the PSUs was $ 8,460 , which is expected to be recognized over a weighted-average period of 2.30 years. 2020 Equity Incentive Plan: In July 2020, the Board of Directors adopted the 2020 Incentive Plan, which was subsequently approved by the Company’s stockholders and became effective on July 30, 2020. Initially, the maximum number of the Company’s common stock that may be issued under the 2020 Incentive Plan was 8,595,871 shares. The 2020 Incentive Plan provides that the number of shares reserved and available for issuance under the 2020 Incentive Plan will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to 4 % of the outstanding number of shares of common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Board of Directors. As of September 29, 2024, 12,418,340 shares were available for future grants of the Company’s common stock, which includes 1,667,385 shares of stock that were automatically added to the available reserve on January 1, 2024. Awards issued under the 2020 Incentive Plan generally have a three-year ratable vesting period beginning on the date of grant. Employee Stock Purchase Plan: In July 2020, the Board of Directors adopted the 2020 ESPP, which was subsequently approved by the Company’s stockholders and became effective on July 30, 2020. The 2020 ESPP authorizes the initial issuance of up to 900,000 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Board of Directors, employees of a related company. The 2020 ESPP provides that the number of shares reserved and available for issuance under the 2020 ESPP will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to the lesser of (i) 1 % of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) 900,000 , or such lesser number of shares as determined by the Board of Directors. As of September 29, 2024, 2,546,083 shares of the Company’s common stock were available for future issuance under the 2020 ESPP, which includes 416,846 shares of common stock that were automatically added to the available reserve on January 1, 2024. The Board of Directors authorizes six-month offering periods, with the most recent beginning on May 16, 2024.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 29, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 16. Income Taxes The Company’s effective tax rate for the 13-week periods ended September 29, 2024 and September 24, 2023 was approximately 28 % and 11 % , respectively. The Company's effective tax rate for the 39-week periods ended September 29, 2024 and September 24, 2023 was approximately 20 % and 19 % , respectively. The Company’s effective tax rate for the 13-week and 39-week periods ended September 29, 2024 differs from the statutory rate due primarily to discrete tax benefits related to the exercise of non-qualified stock options and the vesting of restricted stock units. For interim periods, the Company's income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions, and other items. The Company’s estimated annual effective tax rate differs from the federal statutory rate of 21% due to state taxes, permanent differences related to the exercise of stock options and the impact of compensation deduction limitations under Internal Revenue Code Section 162(m).

Net Income Per Share

Net Income Per Share	9 Months Ended
	Sep. 29, 2024
Earnings Per Share [Abstract]
Net Income Per Share	Note 17. Net Income Per Share Basic and diluted net income per share attributable to Vital Farms, Inc. common stockholders were calculated as follows: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Numerator: Net income $ 7,446 $ 4,523 $ 42,808 $ 18,356 Denominator: Weighted average common shares outstanding — basic 43,249,234 41,375,008 42,517,088 41,037,778 Weighted average effect of potentially dilutive securities: Effect of potentially dilutive stock options 1,600,181 1,724,406 1,932,870 2,133,359 Effect of potentially dilutive RSUs 380,166 33,359 342,086 116,781 Effect of potentially dilutive PSUs 234,211 — 127,606 — Effect of potentially dilutive common stock issuable pursuant to the ESPP 70 2,806 4,034 11,980 Weighted average common shares outstanding — diluted 45,463,862 43,135,579 44,923,684 43,299,898 Net income per share attributable to Vital Farms, Inc. stockholders Basic $ 0.17 $ 0.11 $ 1.01 $ 0.45 Diluted $ 0.16 $ 0.10 $ 0.95 $ 0.42 The Company excluded the following shares of common stock, outstanding at each period end, from the computation of diluted net income per share attributable to Vital Farms, Inc. common stockholders for the periods indicated because including them would have had an anti-dilutive effect: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Options to purchase common stock - 434 499 14,287 Unvested RSUs 1,668 47,789 4,972 8,362 Unvested PSUs 540 - 2,115 - 2,208 48,223 7,586 22,649

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	Sep. 29, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income	Note 18. Accumulated Other Comprehensive Income The amounts reclassified from accumulated other comprehensive income (“AOCI”) to the unaudited consolidated statements of operations were as follows (in thousands): Amounts Reclassified from AOCI 13-Week Period Ended AOCI Component Statement of Income Classification September 29, September 24, Losses on available-for-sale securities Other expense, net $ — $ 53 Total before tax $ — 53 Tax benefit $ — ( 14 ) Net of tax $ — $ 39 Amounts Reclassified from AOCI 39-Week Period Ended AOCI Component Statement of Income Classification September 29, September 24, Losses on available-for-sale securities Other expense, net $ ( 1 ) $ 182 Total before tax ( 1 ) 182 Tax benefit — ( 46 ) Net of tax $ ( 1 ) $ 136 The gross amount and related tax (expense) benefit recorded in, and associated with, each component of other comprehensive income were as follows (in thousands): 13-Weeks Ended September 29, 2024 September 24, 2023 Before Tax Tax After Tax Before Tax Tax After Tax Available-for-sale debt securities: Unrealized net holding gain 138 $ ( 34 ) $ 104 $ 271 $ ( 71 ) $ 200 Amounts reclassified for realized losses to earnings — — — 53 ( 14 ) 39 Total other comprehensive income $ 138 $ ( 34 ) $ 104 $ 324 $ ( 85 ) $ 239 39-Weeks Ended September 29, 2024 September 24, 2023 Before Tax Tax After Tax Before Tax Tax After Tax Available-for-sale debt securities: Unrealized net holding gain $ 416 $ ( 102 ) $ 314 $ 916 $ ( 230 ) $ 686 Amounts reclassified for realized losses to earnings ( 1 ) - ( 1 ) 182 ( 46 ) 136 Total other comprehensive income $ 415 $ ( 102 ) $ 313 $ 1,098 $ ( 276 ) $ 822

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 19. Commitments and Contingencies Supplier Contracts: The Company purchases its egg inventories under long-term supply contracts with farms. Purchase commitments contained in these arrangements are variable and dependent on the quantity of eggs produced by the farms. Accordingly, there are no estimable future purchase commitments associated with these supplier contracts, and there are no minimum payments associated with these long-term supply contracts. The Company records the total cost of eggs into inventory and they are expensed to cost of goods sold when the associated eggs are sold to customers and are also reported as part of the Company’s variable lease cost. The Company has entered into agreements with certain qualifying suppliers to provide a one-time payment of up to $ 200,000 , for the purpose of funding costs associated with farm startup. The payment of these incremental costs is contingent upon the achievement of certain milestones and is to be made no later than 90 days prior to the pullet placement date specified in each supplier agreement. Upon the achievement of such milestones, the Company recognizes an operating ROU asset and lease liability as a cost of obtaining the embedded lease within the supplier contract, which is included in “Leases” in Note 10 above. As of September 29, 2024, $ 9.4 million has been paid out and $ 1.8 million remains to be paid. Indemnification Agreements: In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of the Board of Directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. As of September 29, 2024, the Company has not incurred any material costs as a result of such indemnification agreements. Litigation: The Company is subject to various claims and contingencies that are in the scope of ordinary and routine litigation incidental to its business, including those related to regulation, litigation, business transactions, employee-related matters and taxes, among others. When the Company becomes aware of a claim or potential claim, the likelihood of any loss or exposure is assessed. Based on these assessments and estimates, the Company may establish reserves, as appropriate. These assessments and estimates are based on the information available to management at the time and involve a significant amount of management judgment. Actual outcomes or losses may differ materially from the Company’s assessments and estimates. On May 20, 2021, the Company and certain of its current and former officers were named as defendants in a class action complaint captioned Nicholas A. Usler et al. v. Vital Farms, Inc. et al. in the United States District Court for the Western District of Texas (the “District Court”). The plaintiffs alleged false advertising claims on behalf of themselves and a putative class of alleged consumers of the Company’s eggs. The named officers of the Company were subsequently dismissed as defendants in this matter. On July 9, 2024, a U.S. Magistrate Judge issued an order and report and recommendation, for review and adoption by the District Court. Collectively, the order and the report and recommendation (i) denied the plaintiffs’ motion for class certification, (ii) excluded the testimony and report of the plaintiffs’ damages expert and (iii) granted summary judgment for the Company with respect to two plaintiffs and three of the plaintiffs’ state claims. On September 23, 2024, the Magistrate Judge ’ s order and report and recommendation was adopted by the District Court, and the plaintiffs did not appeal the District Court’s ruling within the required timeline. Although the District Court ’ s order foreclosed the matter proceeding as a class action, the plaintiffs may choose to proceed with remaining individual claims. However, the Company does not anticipate that these claims would be material to the Company individually or in the aggregate. Although the Company maintains insurance for certain potential liabilities, such insurance does not cover all types and amounts of potential liabilities and is subject to various exclusions and caps on amounts recoverable. Even if the Company believes a claim is covered by insurance, insurers may dispute the Company’s entitlement to recovery for a variety of potential reasons, which may affect the timing and, if the insurers prevail, the amount of the Company’ s recovery. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company records a liability for the loss. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 29, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 20. Related Party Transactions Sandpebble Builders Preconstruction, Inc.: The Company utilizes Sandpebble Builders Preconstruction, Inc. and Sandpebble South, Inc. (collectively “Sandpebble”) for project management and related services associated with the construction and expansion of the Company’s egg processing facilities, including site selection, project management and related services for the Company’s planned egg packing facility in Seymour, Indiana. The Company’s contract with Sandpebble for services related to the Company’s planned egg packing facility in Seymour, Indiana was awarded after a competitive bidding process. Victor Canseco, the owner and principal of Sandpebble, is the father of Russell Diez-Canseco, the Company’s President and Chief Executive Officer and a member of the Board of Directors. In connection with the services described above, the Company paid Sandpebble $ 213 and $ 158 during the 13-week periods ended September 29, 2024 and September 24, 2023, respectively, and $ 753 and $ 413 during the 39-week periods ended September 29, 2024 and September 24, 2023, respectively. Amounts paid to Sandpebble are included in property, plant and equipment, net and selling, general and administrative costs. As of September 29, 2024 and September 24, 2023, amounts owed to Sandpebble were $ 122 and $ 347 , respectively, and are included in accrued liabilities.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 29, 2024
Accounting Policies [Abstract]
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements The new accounting pronouncements recently adopted by the Company are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 31, 2023, and the notes thereto, which are included in the Annual Report. There have been no new accounting pronouncements adopted by the Company during the 39-week period ended September 29, 2024.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU 2023-07, Segment Reporting (Topic 280) — Improvements to Reportable Segment Disclosures (“ASU 2023-07”) in order to improve stockholders’ understanding of an entity’s business activities through enhanced disclosures around reportable segments. ASU 2023-07 will require incremental and more detailed disclosure regarding segment expenses on both an annual and interim basis. For public companies ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company plans to adopt the standard for the year ended December 29, 2024 and will thus include any additional disclosures in its Annual Report on Form 10-K for the current fiscal year. In December 2023, the FASB issued ASU No 2023-09, Income Taxes (Topic 740) — Improvements to Income Tax Disclosures (“ASU 2023-09”) in order to enhance the transparency and usefulness of income tax disclosures. The guidance is applicable to all entities subject to income tax and it will require disclosure of certain categories within the rate reconciliation to improve consistency as well as disclosure of reconciling items which meet a certain quantitative threshold which will improve transparency. Additionally, entities must disclose the amount of taxes paid to federal, state and foreign municipalities. For public companies, ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company expects to adopt the standard for the fiscal year beginning December 30, 2024. The Company is currently evaluating the impact of its pending adoption of ASU 2023-09 on its consolidated financial statements.

Investment Securities (Tables)

Investment Securities (Tables)	9 Months Ended
	Sep. 29, 2024
Investments, Debt and Equity Securities [Abstract]
Summary of Available-for-sale Investment Securities	The following table summarizes the Company’s available-for-sale investment securities as of September 29, 2024: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value U.S. corporate bonds and U.S. dollar $ 13,531 $ 17 $ ( 68 ) $ — $ 13,480 Total $ 13,531 $ 17 $ ( 68 ) $ — $ 13,480 The following table summarizes the Company’s available-for-sale investment securities as of December 31, 2023: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value U.S. corporate bonds and U.S. dollar $ 33,134 $ 10 $ ( 477 ) $ — $ 32,667 Total $ 33,134 $ 10 $ ( 477 ) $ — $ 32,667
Summary of Contractual Maturities of Investment Securities	The amortized cost and fair value of the Company’s investments in available-for-sale securities as of September 29, 2024 by contractual maturity are as follows: Amortized Cost Fair Value Due within one year $ 12,518 $ 12,456 Due after one year through five years 1,013 1,024 Total available-for-sale $ 13,531 $ 13,480
Schedule of Unrealized Loss Aging for Available-for-sale Securities	The following tables present the Company ’s unrealized loss aging for available-for-sale securities by type and length of time the security was in a continuous unrealized loss position as of the periods presented: September 29, 2024 Less than 12 months 12 months or longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. corporate bonds and U.S. dollar $ - $ - $ 11,801 $ ( 68 ) $ 11,801 $ ( 68 ) Total $ - $ - $ 11,801 $ ( 68 ) $ 11,801 $ ( 68 ) December 31, 2023 Less than 12 months 12 months or longer Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. corporate bonds and U.S. dollar $ 699 $ ( 3 ) $ 29,247 $ ( 474 ) $ 29,946 $ ( 477 ) Total $ 699 $ ( 3 ) $ 29,247 $ ( 474 ) $ 29,946 $ ( 477 )

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule Of Notional Amounts of Outstanding Derivative Instruments	The following table presents the aggregated outstanding notional amounts related to the Company’s derivative financial instruments for the periods presented: Metric September 29, December 31, Commodity: Corn Bushels (in thousands) 860 2,351 Soybean Meal Tons — 25

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 29, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value	The following tables present information about the Company’s financial assets measured at fair value on a recurring basis for the periods presented: Fair Value Measurements as of September 29, 2024, Using: Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market $ 109,157 $ — $ — $ 109,157 Investment securities, available-for-sale: U.S. corporate bonds and U.S. dollar — 13,480 — 13,480 Total assets measured at fair value $ 109,157 $ 13,480 $ — $ 122,637 Fair Value Measurements as of December 31, 2023, Using: Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents: Money market $ 64,498 $ — $ — $ 64,498 Investment securities, available-for-sale: U.S. corporate bonds and U.S. dollar — 32,667 — 32,667 Derivative financial instruments — 394 — 394 Total assets measured at fair value $ 64,498 $ 33,061 $ — $ 97,559

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 29, 2024
Revenue from Contract with Customer [Abstract]
Summary of Net Revenue by Primary Product	The following table summarizes the Company’s net revenue by primary product for the periods presented: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Net Revenue: Eggs and egg-related products $ 138,142 $ 103,887 $ 424,863 $ 318,462 Butter and butter-related products 6,860 6,542 15,455 17,584 Net Revenue $ 145,002 $ 110,429 $ 440,318 $ 336,046
Summary of Percentage of Net Revenue and Accounts Receivable, Net Due from Significant Customers	The percentage of net revenue from significant customers during the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023 is as follows: Net Revenue Net Revenue Net Revenue Net Revenue Customer A 24 % 24 % 24 % 25 % Customer B 10 % * 10 % * * Net revenue was less than 10% As of September 29, 2024 and December 31, 2023 , the Company had customers that individually exceeded 10% or more of the Company’s accounts receivable. The percentage of accounts receivable, net due from significant customers as of September 29, 2024 and December 31, 2023 is as follows: Accounts Receivable, Net as of September 29, 2024 Accounts Receivable, Net as of December 31, 2023 Customer A 14 % 18 % Customer B 10 % 12 % Customer C * 11 % Customer D 10 % 11 % Customer E 14 % * * Accounts receivable, net was less than 10%

Allowance for Credit Losses (Ta

Allowance for Credit Losses (Tables)	9 Months Ended
	Sep. 29, 2024
Allowance for Credit Loss [Abstract]
Schedule of Changes in Allowance for Credit Losses	Changes in the allowance for credit losses for the 39-week period ended September 29, 2024 were as follows: Accounts Receivable Prepaid Expenses and other Current Assets Total As of December 31, 2023 $ ( 550 ) $ ( 227 ) $ ( 777 ) Reductions (provisions) charged to operating results 284 ( 48 ) 236 Account write-offs — 140 140 As of March 31, 2024 $ ( 266 ) $ ( 135 ) $ ( 401 ) (Provisions) reductions charged to operating results ( 248 ) 18 ( 230 ) Account write-offs — — — As of June 30, 2024 $ ( 514 ) $ ( 117 ) $ ( 631 ) (Provisions) reductions charged to operating results ( 45 ) ( 75 ) ( 120 ) Account write-offs — — — As of September 29, 2024 $ ( 559 ) $ ( 192 ) $ ( 751 )

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 29, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory consisted of the following as of the periods presented: September 29, December 31, Eggs and egg-related products $ 18,980 $ 25,521 Butter and butter-related products 8,344 1,697 Packaging 4,158 4,988 Pullets 847 289 Other 1,236 896 Reserve for inventory obsolescence ( 173 ) ( 496 ) Inventories $ 33,392 $ 32,895

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
	Sep. 29, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consisted of the following as of the periods presented: September 29, December 31, Land $ 6,549 $ 552 Land improvements 818 818 Buildings and improvements 30,502 30,532 Vehicles 1,179 1,055 Machinery and equipment 56,672 50,979 Leasehold improvements 491 492 Furniture and fixtures 535 461 Construction in progress 3,216 3,001 99,962 87,890 Less: Accumulated depreciation and amortization ( 30,693 ) ( 21,051 ) Property, plant and equipment, net $ 69,269 $ 66,839

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 29, 2024
Leases [Abstract]
Schedule of Components of Lease Cost	The components of lease cost, classified within cost of goods sold, selling, general and administrative and interest expense for the 13-week and 39-week periods ended September 29, 2024 and September 24, 2023 are below: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Operating lease cost $ 1,271 $ 411 $ 3,255 $ 1,133 Finance lease cost – amortization of ROU assets 999 808 $ 2,851 1,702 Finance lease cost – interest on lease liabilities 238 238 $ 723 495 Short-term lease cost 39 316 $ 107 738 Variable lease cost 2,971 973 $ 8,073 4,651 Variable lease cost – long-term supply contracts 54,496 48,453 $ 164,928 138,603 Total lease cost $ 60,014 $ 51,199 $ 179,937 $ 147,322
Summary of Operating and Finance Leases Future Undiscounted Cash Flows	Future undiscounted cash flows are as follows: As of September 29, 2024 Operating Leases Finance Leases 2024 $ 2,430 $ 1,150 2025 3,434 4,633 2026 3,018 4,670 2027 — 3,850 Total lease payments 8,882 14,303 Less imputed interest ( 542 ) ( 1,428 ) Total present value of lease liabilities $ 8,340 $ 12,875

Goodwill and Other Assets (Tabl

Goodwill and Other Assets (Tables)	9 Months Ended
	Sep. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill and Other Assets	Goodwill and other assets consisted of the following as of the periods presented: September 29, December 31, Goodwill $ 3,858 $ 3,858 Software development costs 2,577 — Other non-current assets 46 46 Goodwill and other assets $ 6,481 $ 3,904 As of September 29, 2024 , the Company has capitalized costs of $ 2,577 relating to cloud computing arrangement implementation costs. This software has been developed by third-party and internal labor and has passed the preliminary project stage prior to capitalization. Amortization of the cloud computing arrangement implementation costs will begin once the software is placed in service.

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	9 Months Ended
	Sep. 29, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following as of the periods presented: September 29, December 31, Employee-related costs $ 15,349 $ 9,131 Promotions and customer deductions 8,787 6,982 Distribution fees and freight 2,427 2,876 Marketing and broker commissions 3,374 3,627 Purchases of inventory 1,648 525 Professional fees 1,338 1,066 Other 422 11 Accrued liabilities $ 33,345 $ 24,218

Common Stock (Tables)

Common Stock (Tables)	9 Months Ended
	Sep. 29, 2024
Equity [Abstract]
Schedule of Reserved Shares of Common Stock for Issuance	As of each balance sheet date, the Company had reserved shares of common stock for issuance in connection with the following: September 29, December 31, Options to purchase common stock 2,043,194 3,920,485 Restricted stock units (“RSUs”) 649,956 565,376 Performance stock units (“PSUs”) 238,704 — Shares available for grant under the 2020 Equity Incentive 14,964,423 13,313,326 Total 17,896,277 17,799,187

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 29, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Recognized Stock - Based Compensation Expense	The Company recognized stock-based compensation expense in the condensed consolidated statements of operations for the periods presented: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Cost of goods sold $ 72 $ 61 $ 226 $ 194 Selling, general and administrative expense 2,602 1,754 7,346 5,308 Total $ 2,674 $ 1,815 $ 7,572 $ 5,502
Summary of Stock Option Activity	The following table summarizes the Company’s stock option activity since December 31, 2023: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2023 3,920,485 $ 10.07 $ 28,749 Granted — $ — Exercised ( 1,818,001 ) $ 6.22 $ 47,872 Cancelled/Forfeited ( 59,290 ) $ 22.59 $ 225 Outstanding as of September 29, 2024 2,043,194 $ 13.13 5.4 $ 44,959 Options exercisable as of September 29, 2024 1,630,749 $ 12.47 4.9 $ 36,949 Options vested and expected to vest as of September 29, 2024 2,043,194 $ 13.13 5.4 $ 44,959
Summary of RSU Activity	The following table summarizes the Company’s RSU activity since December 31, 2023: Number of Weighted- Unvested as of December 31, 2023 565,376 $ 14.24 Granted 415,014 $ 22.46 Vested 1 ( 253,711 ) $ 14.40 Forfeited ( 76,723 ) $ 16.89 Unvested as of September 29, 2024 649,956 $ 19.12 1 Includes 67,728 shares of common stock withheld to cover taxes on the release of vested RSUs, which became available for future grants pursuant to the 2020 Equity Incentive Plan.
Summary of PSU activity	The following table summarizes the Company’s PSU activity since December 31, 2023: Number of Weighted- Unvested as of December 31, 2023 — $ — Granted 255,019 $ 21.73 Forfeited ( 16,315 ) $ 20.99 Unvested as of September 29, 2024 238,704 $ 21.78

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Sep. 29, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Income Per Share	Basic and diluted net income per share attributable to Vital Farms, Inc. common stockholders were calculated as follows: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Numerator: Net income $ 7,446 $ 4,523 $ 42,808 $ 18,356 Denominator: Weighted average common shares outstanding — basic 43,249,234 41,375,008 42,517,088 41,037,778 Weighted average effect of potentially dilutive securities: Effect of potentially dilutive stock options 1,600,181 1,724,406 1,932,870 2,133,359 Effect of potentially dilutive RSUs 380,166 33,359 342,086 116,781 Effect of potentially dilutive PSUs 234,211 — 127,606 — Effect of potentially dilutive common stock issuable pursuant to the ESPP 70 2,806 4,034 11,980 Weighted average common shares outstanding — diluted 45,463,862 43,135,579 44,923,684 43,299,898 Net income per share attributable to Vital Farms, Inc. stockholders Basic $ 0.17 $ 0.11 $ 1.01 $ 0.45 Diluted $ 0.16 $ 0.10 $ 0.95 $ 0.42
Schedule of Common Shares Excluded from Computation of Diluted Earnings Per Share	The Company excluded the following shares of common stock, outstanding at each period end, from the computation of diluted net income per share attributable to Vital Farms, Inc. common stockholders for the periods indicated because including them would have had an anti-dilutive effect: 13-Weeks Ended 39-Weeks Ended September 29, September 24, September 29, September 24, Options to purchase common stock - 434 499 14,287 Unvested RSUs 1,668 47,789 4,972 8,362 Unvested PSUs 540 - 2,115 - 2,208 48,223 7,586 22,649

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Sep. 29, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	The amounts reclassified from accumulated other comprehensive income (“AOCI”) to the unaudited consolidated statements of operations were as follows (in thousands): Amounts Reclassified from AOCI 13-Week Period Ended AOCI Component Statement of Income Classification September 29, September 24, Losses on available-for-sale securities Other expense, net $ — $ 53 Total before tax $ — 53 Tax benefit $ — ( 14 ) Net of tax $ — $ 39 Amounts Reclassified from AOCI 39-Week Period Ended AOCI Component Statement of Income Classification September 29, September 24, Losses on available-for-sale securities Other expense, net $ ( 1 ) $ 182 Total before tax ( 1 ) 182 Tax benefit — ( 46 ) Net of tax $ ( 1 ) $ 136
Schedule of Component of Other Comprehensive Income	The gross amount and related tax (expense) benefit recorded in, and associated with, each component of other comprehensive income were as follows (in thousands): 13-Weeks Ended September 29, 2024 September 24, 2023 Before Tax Tax After Tax Before Tax Tax After Tax Available-for-sale debt securities: Unrealized net holding gain 138 $ ( 34 ) $ 104 $ 271 $ ( 71 ) $ 200 Amounts reclassified for realized losses to earnings — — — 53 ( 14 ) 39 Total other comprehensive income $ 138 $ ( 34 ) $ 104 $ 324 $ ( 85 ) $ 239 39-Weeks Ended September 29, 2024 September 24, 2023 Before Tax Tax After Tax Before Tax Tax After Tax Available-for-sale debt securities: Unrealized net holding gain $ 416 $ ( 102 ) $ 314 $ 916 $ ( 230 ) $ 686 Amounts reclassified for realized losses to earnings ( 1 ) - ( 1 ) 182 ( 46 ) 136 Total other comprehensive income $ 415 $ ( 102 ) $ 313 $ 1,098 $ ( 276 ) $ 822

Nature of the Business and Ba_2

Nature of the Business and Basis of Presentation - Additional Information (Details)	9 Months Ended
	Sep. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Date of incorporation	Jun. 06, 2013

Investment Securities - Summary

Investment Securities - Summary of Available-for-sale Investment Securities (Details) - USD ($)	Sep. 29, 2024	Dec. 31, 2023
Schedule Of Available For Sale Securities [Line Items]
Total available-for-sale Amortized Cost	$ 13,531,000	$ 33,134,000
Unrealized Gains	17,000	10,000
Unrealized Losses	(68,000)	(477,000)
Allowance for Credit Losses	0	0
Fair Value	13,480,000	32,667,000
U.S. corporate bonds and U.S. dollar denominated foreign bonds
Schedule Of Available For Sale Securities [Line Items]
Total available-for-sale Amortized Cost	13,531,000	33,134,000
Unrealized Gains	17,000	10,000
Unrealized Losses	(68,000)	(477,000)
Allowance for Credit Losses	0	0
Fair Value	$ 13,480,000	$ 32,667,000

Investment Securities - Additio

Investment Securities - Additional Information (Details)	3 Months Ended		9 Months Ended
	Sep. 29, 2024 USD ($) Position Security	Sep. 24, 2023 USD ($)	Sep. 29, 2024 USD ($) Position Security	Sep. 24, 2023 USD ($)	Dec. 31, 2023 USD ($)
Schedule Of Available For Sale Securities [Line Items]
Proceeds from the sale of available-for-sale securities	$ 0	$ 988,000	$ 0	$ 2,895,000
Unrealized Losses	$ 68,000		$ 68,000		$ 477,000
Unrealized Loss Position greater than 12 months | Position	17		17
Allowance for Credit Losses	$ 0		$ 0		$ 0
Maximum
Schedule Of Available For Sale Securities [Line Items]
Unrealized Losses	$ 8,000		$ 8,000
AFS Securities
Schedule Of Available For Sale Securities [Line Items]
Number of Securities Issuances for unrealized losses | Security	17		17

Investment Securities - Summa_2

Investment Securities - Summary of Contractual Maturities of Investment Securities (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Due within one year Amortized Cost	$ 12,518
Due after one year through five years Amortized Cost	1,013
Total available-for-sale Amortized Cost	13,531	$ 33,134
Due within one year Fair Value	12,456
Due after one year through five years Fair Value	1,024
Total available-for-sale Fair Value	$ 13,480	$ 32,667

Investment Securities - Schedul

Investment Securities - Schedule of Unrealized Loss Aging for Available-for-sale Securities (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Schedule Of Available For Sale Securities [Line Items]
Fair value, less than 12 months	$ 0	$ 699
Unrealized losses, less than 12 months	0	(3)
Fair value, 12 months or longer	11,801	29,247
Unrealized losses, 12 months or longer	(68)	(474)
Fair value, Total	11,801	29,946
Unrealized losses, Total	(68)	(477)
U.S. corporate bonds and U.S. dollar denominated foreign bonds
Schedule Of Available For Sale Securities [Line Items]
Fair value, less than 12 months	0	699
Unrealized losses, less than 12 months	0	(3)
Fair value, 12 months or longer	11,801	29,247
Unrealized losses, 12 months or longer	(68)	(474)
Fair value, Total	11,801	29,946
Unrealized losses, Total	$ (68)	$ (477)

Derivative Financial Instrume_3

Derivative Financial Instruments - Schedule Of Notional Amounts of Outstanding Derivative Instruments (Details) bu in Thousands	Sep. 29, 2024 bu T	Dec. 31, 2023 bu T
Corn
Derivative [Line Items]
Notional amounts of derivative financial instruments | bu	860	2,351
Soybean Meal
Derivative [Line Items]
Notional amounts of derivative financial instruments | T	0	25

Derivative Financial Instrume_4

Derivative Financial Instruments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Commodity Contract [Member] | Non designated [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of derivative losses	$ 6	$ 588	$ 393	$ 2,405

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value (Details) - Recurring - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	$ 122,637	$ 97,559
Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	109,157	64,498
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	13,480	33,061
Money market
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	109,157	64,498
Money market | Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	109,157	64,498
U.S. corporate bonds and U.S. dollar denominated foreign bonds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	13,480	32,667
U.S. corporate bonds and U.S. dollar denominated foreign bonds | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	$ 13,480	32,667
Derivative financial instruments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value		394
Derivative financial instruments | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value		$ 394

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	Sep. 29, 2024 USD ($)
Fair Value Disclosures [Abstract]
Fair value liabilities transfers, Level 2 to Level 1	$ 0

Revenue Recognition - Summary o

Revenue Recognition - Summary of Net Revenue by Primary Product (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Disaggregation Of Revenue [Line Items]
Net revenue	$ 145,002	$ 110,429	$ 440,318	$ 336,046
Eggs and Egg Related Products
Disaggregation Of Revenue [Line Items]
Net revenue	138,142	103,887	424,863	318,462
Butter and Butter Related Products
Disaggregation Of Revenue [Line Items]
Net revenue	$ 6,860	$ 6,542	$ 15,455	$ 17,584

Revenue Recognition - Summary_2

Revenue Recognition - Summary of Percentage of Net Revenue from Significant Customers (Details) - Customer Concentration Risk - Net Revenue	3 Months Ended		6 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Customer A
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	24%	24%	24%	25%
Customer B
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	10%		10%

Revenue Recognition - Summary_3

Revenue Recognition - Summary of Percentage of Accounts Receivable, Net Due from Significant Customers (Details) - Customer Concentration Risk - Accounts Receivable	9 Months Ended	12 Months Ended
	Sep. 29, 2024	Dec. 31, 2023
Customer A
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	14%	18%
Customer B
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	10%	12%
Customer C
Disaggregation Of Revenue [Line Items]
Concentration risk percentage		11%
Customer D
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	10%	11%
Customer E
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	14%

Allowance for Credit Losses - A

Allowance for Credit Losses - Additional Information (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Allowance for Credit Loss [Abstract]
Allowance for credit losses	$ 751	$ 631	$ 401	$ 777

Allowance for Credit Losses - S

Allowance for Credit Losses - Schedule of Changes in Allowance for Credit Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 29, 2024	Jun. 30, 2024	Mar. 31, 2024
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses, Beginning balance	$ (631)	$ (401)	$ (777)
(Provisions) reductions charged to operating results	(120)	(230)	236
Account write-off	0	0	140
Allowance for credit losses,Ending balance	(751)	(631)	(401)
Trade Receivable [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses, Beginning balance	(514)	(266)	(550)
(Provisions) reductions charged to operating results	(45)	(248)	284
Account write-off	0	0	0
Allowance for credit losses,Ending balance	(559)	(514)	(266)
Prepaid Expenses and other Current Assets [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses, Beginning balance	(117)	(135)	(227)
(Provisions) reductions charged to operating results	(75)	18	(48)
Account write-off	0	0	140
Allowance for credit losses,Ending balance	$ (192)	$ (117)	$ (135)

Inventories - Schedule of Inven

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Inventory [Line Items]
Reserve for inventory obsolescence	$ (173)	$ (496)
Inventories	33,392	32,895
Eggs and Egg Related Products
Inventory [Line Items]
Inventory gross	18,980	25,521
Butter and Butter Related Products
Inventory [Line Items]
Inventory gross	8,344	1,697
Packaging
Inventory [Line Items]
Inventory gross	4,158	4,988
Pullets
Inventory [Line Items]
Inventory gross	847	289
Other
Inventory [Line Items]
Inventory gross	$ 1,236	$ 896

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets - Schedule of prepaid expenses and other current assets (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid expenses and other current assets, net	$ 6,446	$ 6,114

Property, Plant and Equipment -

Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 99,962	$ 87,890
Less: Accumulated depreciation and amortization	(30,693)	(21,051)
Property, plant and equipment, net	69,269	66,839
Land
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	6,549	552
Land improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	818	818
Buildings and Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	30,502	30,532
Vehicles
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	1,179	1,055
Machinery and Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	56,672	50,979
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	491	492
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	535	461
Construction in Progress
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 3,216	$ 3,001

Property, Plant and Equipment_2

Property, Plant and Equipment - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Property Plant And Equipment [Line Items]
Depreciation and amortization of property, plant and equipment	$ 2,331	$ 2,052	$ 6,978	$ 5,595
Amortization of property, plant and equipment	$ 999	$ 808	$ 2,851	$ 1,702

Leases - Schedule of Components

Leases - Schedule of Components of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Leases [Abstract]
Operating lease cost	$ 1,271	$ 411	$ 3,255	$ 1,133
Finance lease cost - amortization of ROU assets	999	808	2,851	1,702
Finance lease cost - interest on lease liabilities	238	238	723	495
Short-term lease cost	39	316	107	738
Variable lease cost	2,971	973	8,073	4,651
Variable lease cost - long-term supply contracts	54,496	48,453	164,928	138,603
Total lease cost	$ 60,014	$ 51,199	$ 179,937	$ 147,322

Leases - Summary of Operating a

Leases - Summary of Operating and Finance Leases Future Undiscounted Cash Flows (Details) $ in Thousands	Sep. 29, 2024 USD ($)
Leases [Abstract]
Operating leases 2024	$ 2,430
Operating leases 2025	3,434
Operating leases 2026	3,018
Operating leases 2027	0
Total lease payments	8,882
Less imputed interest	(542)
Total present value of lease liabilities	8,340
Finance leases 2024	1,150
Finance leases 2025	4,633
Finance leases 2026	4,670
Finance leases 2027	3,850
Total lease payments	14,303
Less imputed interest	(1,428)
Total present value of lease liabilities	$ 12,875

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023
Leases [Abstract]
ROU assets obtained in exchange for new finance lease obligations	$ 1,753	$ 7,132
ROU assets obtained in exchange for new operating lease obligations	$ 11,203	$ 703

Goodwill and Other Assets - Sch

Goodwill and Other Assets - Schedule of Goodwill and Other Assets (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 3,858	$ 3,858
Software development costs	2,577	0
Other non-current assets	46	46
Goodwill and other assets	$ 6,481	$ 3,904

Goodwill and Other Assets - Add

Goodwill and Other Assets - Additional Information (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Software development costs	$ 2,577	$ 0

Accrued Liabilities - Schedule

Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 29, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Employee-related costs	$ 15,349	$ 9,131
Promotions and customer deductions	8,787	6,982
Distribution fees and freight	2,427	2,876
Marketing and broker commissions	3,374	3,627
Purchases of inventory	1,648	525
Professional fees	1,338	1,066
Other	422	11
Accrued liabilities	$ 33,345	$ 24,218

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Apr. 09, 2024	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Revolving Line of Credit
Debt Instrument [Line Items]
Interest expense		$ 0	$ 0	$ 0	$ 7
PNC Bank, National Association
Debt Instrument [Line Items]
Credit Facility Termination Date				Apr. 09, 2024
PNC Bank, National Association | Revolving Line of Credit | Sixth Amendment
Debt Instrument [Line Items]
Line of credit facility maximum borrowing capacity		20,000		$ 20,000
PNC Bank, National Association | Revolving Line of Credit | Tenth Amendment | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate				2%
PNC Bank, National Association | Revolving Line of Credit | Tenth Amendment | Alternate Base Rate
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate				1%
PNC Bank, National Association | Credit Facility
Debt Instrument [Line Items]
Line of credit facility covenant terms				The PNC Credit Facility was secured by all of the Company’s assets (other than real property and certain other property excluded pursuant to the terms of the PNC Credit Facility) and required the Company to maintain three financial covenants: a fixed charge coverage ratio, a leverage ratio and a minimum tangible net worth requirement. The PNC Credit Facility also contained various covenants relating to limitations on indebtedness, acquisitions, mergers, consolidations and the sale of properties and liens.
JP Morgan Chase Bank NA | Revolving Line of Credit
Debt Instrument [Line Items]
Line of credit facility maximum borrowing capacity	$ 60,000
JPMorgan Credit Facility
Debt Instrument [Line Items]
Debt instrument face amount	$ 35,000
Percentage of debt instrument face amount	100%
Outstanding Debt		$ 0		$ 0
Letter of credit sub-limit	$ 5,000
Revolving credit facility interest rate description	Any borrowings under the JPMorgan Credit Facility bear interest, at the Company’s election, at either (i) an adjusted term Secured Overnight Financing Rate or adjusted daily Secured Overnight Financing Rate plus 0.10% plus a margin of either 0.75%, 1.00% or 1.25% depending on the Company’s net leverage ratio or (ii) an alternative base rate plus a margin or either 1.75%, 2.00% or 2.25%, depending on the Company’s net leverage ratio. The Company is required to pay a commitment fee on the undrawn portion of the aggregate commitments that accrues at either 0.20% or 0.375% per annum depending on the Company’s revolving exposure.
Leverage ratio	3.25%
Increase in leverage ratio	4%
Minimum fixed charge coverage ratio	1.35%
JPMorgan Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate	0.10%

Common Stock - Additional Infor

Common Stock - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 29, 2024	Dec. 31, 2023
Class Of Stock [Line Items]
Common stock, shares authorized	310,000,000	310,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares issued	43,705,476	41,684,649
Common stock, shares outstanding	43,705,476	41,684,649
Common stock voting rights	Each share of the Company’s common stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders.
Common stock dividend declared or paid	$ 0

Common Stock - Schedule of Rese

Common Stock - Schedule of Reserved Shares of Common Stock for Issuance (Details) - shares	Sep. 29, 2024	Dec. 31, 2023
Class Of Stock [Line Items]
Common stock for issuance	17,896,277	17,799,187
Employee Stock Option
Class Of Stock [Line Items]
Common stock for issuance	2,043,194	3,920,485
RSUs
Class Of Stock [Line Items]
Common stock for issuance	649,956	565,376
PSUs
Class Of Stock [Line Items]
Common stock for issuance	238,704
Shares Available for Grant | 2020 Equity Incentive Plan ("2020 Incentive Plan") and 2020 Employee Stock Purchase Plan ("2020 ESPP")
Class Of Stock [Line Items]
Common stock for issuance	14,964,423	13,313,326

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Thousands			1 Months Ended	3 Months Ended		9 Months Ended
		Jan. 01, 2024	Jul. 31, 2020	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023	Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock for issuance				17,896,277		17,896,277		17,799,187
Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation expense				$ 1,347		$ 1,347
Fair value of shares vested				$ 1,065	$ 1,633	$ 2,965	$ 2,905
Expected weighted-average period of recognition						1 year 4 months 13 days
Stock options - vest year						3 years
Stock options - date of grant and expire						10 years
Common stock for issuance				2,043,194		2,043,194		3,920,485
RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation expense				$ 9,484		$ 9,484
Fair value of shares vested				$ 75	113	$ 3,655	3,026
Vested	[1]					(253,711)
Expected weighted-average period of recognition						2 years 1 month 2 days
Stock options - vest year						3 years
Common stock for issuance				649,956		649,956		565,376
PSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation expense				$ 8,460		$ 8,460
Fair value of shares vested				$ 0	$ 0	$ 0	$ 0
Vested				0	0	0	0
Expected weighted-average period of recognition						2 years 3 months 18 days
Stock options - vest year						3 years
Common stock for issuance				238,704		238,704
PSUs | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of number of shares earned						200%
PSUs | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of number of shares earned						0%
2020 Equity Incentive Plan | Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of shares issuable			8,595,871
Percentage of outstanding common stock			4%
Share-based compensation award, description						Initially, the maximum number of the Company’s common stock that may be issued under the 2020 Incentive Plan was 8,595,871 shares. The 2020 Incentive Plan provides that the number of shares reserved and available for issuance under the 2020 Incentive Plan will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to 4% of the outstanding number of shares of common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Board of Directors.
Number of shares available for future grants				12,418,340		12,418,340
Number of new shares issued		1,667,385
2020 Employee Stock Purchase Plan | Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of shares issuable			900,000
Percentage of outstanding common stock			1%
Share-based compensation award, description						The 2020 ESPP authorizes the initial issuance of up to 900,000 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Board of Directors, employees of a related company. The 2020 ESPP provides that the number of shares reserved and available for issuance under the 2020 ESPP will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) 900,000, or such lesser number of shares as determined by the Board of Directors.
Number of new shares issued		416,846
Common stock for issuance				2,546,083		2,546,083
[1] Includes 67,728 shares of common stock withheld to cover taxes on the release of vested RSUs, which became available for future grants pursuant to the 2020 Equity Incentive Plan.

Stock-Based Compensation -Summa

Stock-Based Compensation -Summary of Recognized Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	$ 2,674	$ 1,815	$ 7,572	$ 5,502
Cost of Goods Sold
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	72	61	226	194
Selling, General and Administrative
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	$ 2,602	$ 1,754	$ 7,346	$ 5,308

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 29, 2024
Share-Based Payment Arrangement [Abstract]
Number of Options, Beginning balance	3,920,485
Number of Options, Granted	0
Number of Options, Exercised	(1,818,001)
Number of Options, Cancelled	(59,290)
Number of Options, Ending balance	2,043,194
Number of Options, Options exercisable as of September 29, 2024	1,630,749
Number of Options, Options vested and expected to vest as of September 29, 2024	2,043,194
Weighted-Average Exercise Price, Beginning balance	$ 10.07
Weighted-Average Exercise Price, Options Granted	0
Weighted-Average Exercise Price, Options Exercised	6.22
Weighted-Average Exercise Price, Options Cancelled	22.59
Weighted-Average Exercise Price, Ending balance	13.13
Weighted-Average Exercise Price, Options exercisable as of September 29, 2024	12.47
Weighted-Average Exercise Price, Options vested and expected to vest as of September 29, 2024	$ 13.13
Weighted Average Remaining Contractual Life (Years), Balance	5 years 4 months 24 days
Weighted Average Remaining Contractual Life (Years), Options exercisable as of September 29, 2024	4 years 10 months 24 days
Weighted Average Remaining Contractual Life (Years), Options vested and expected to vest as of September 29, 2024	5 years 4 months 24 days
Aggregate Intrinsic Value, Beginning balance	$ 28,749
Aggregate Intrinsic Value, Exercised	47,872
Aggregate Intrinsic Value, Cancelled	225
Aggregate Intrinsic Value, Ending balance	44,959
Aggregate Intrinsic Value, Options exercisable as of September 29, 2024	36,949
Aggregate Intrinsic Value, Options vested and expected to vest as of September 29, 2024	$ 44,959

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of RSU Activity (Details) - RSUs	9 Months Ended
	Sep. 29, 2024 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unvested as of December 31, 2023 | shares	565,376
Granted | shares	415,014
Vested | shares	(253,711)	[1]
Forfeited | shares	(76,723)
Unvested as of September 29, 2024 | shares	649,956
Weighted-Average Grant Date Fair Value, Beginning balance | $ / shares	$ 14.24
Weighted-Average Grant Date Fair Value, Granted | $ / shares	22.46
Weighted-Average Grant Date Fair Value, Vested | $ / shares	14.4	[1]
Weighted-Average Grant Date Fair Value, Forfeited | $ / shares	16.89
Weighted-Average Grant Date Fair Value, Ending balance | $ / shares	$ 19.12
[1] Includes 67,728 shares of common stock withheld to cover taxes on the release of vested RSUs, which became available for future grants pursuant to the 2020 Equity Incentive Plan.

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of RSU Activity (Parenthetical) (Details)	9 Months Ended
	Sep. 29, 2024 shares
RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares of common stock withheld to cover taxes	67,728

Stock-Based Compensation - Su_4

Stock-Based Compensation - Summary of PSU Activity (Details) - PSUs	9 Months Ended
	Sep. 29, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested as of December 31, 2023 | shares	0
Granted | shares	255,019
Forfeited | shares	(16,315)
Unvested as of September 29, 2024 | shares	238,704
Weighted-Average Grant Date Fair Value, Beginning balance | $ / shares	$ 0
Weighted-Average Grant Date Fair Value, Granted | $ / shares	21.73
Weighted-Average Grant Date Fair Value, Forfeited | $ / shares	20.99
Weighted-Average Grant Date Fair Value, Ending balance | $ / shares	$ 21.78

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Income Tax Disclosure [Abstract]
Effective tax rate	28%	11%	20%	19%

Net Income Per Share - Schedule

Net Income Per Share - Schedule of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Numerator:
Net income	$ 7,446	$ 4,523	$ 42,808	$ 18,356
Denominator:
Weighted average common shares outstanding — basic	43,249,234	41,375,008	42,517,088	41,037,778
Weighted average effect of potentially dilutive securities:
Weighted average common shares outstanding — diluted	45,463,862	43,135,579	44,923,684	43,299,898
Net income (loss) per share attributable to Vital Farms, Inc. stockholders
Basic	$ 0.17	$ 0.11	$ 1.01	$ 0.45
Diluted	$ 0.16	$ 0.1	$ 0.95	$ 0.42
Employee Stock Option
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive stock options	1,600,181	1,724,406	1,932,870	2,133,359
RSUs
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive stock options	380,166	33,359	342,086	116,781
Employee Stock Purchase Plan
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive stock options	70	2,806	4,034	11,980
PSUs
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive stock options	234,211		127,606

Net Income Per Share - Schedu_2

Net Income Per Share - Schedule of Excluded Common Shares Including at Anti-dilutive Effect (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	2,208	48,223	7,586	22,649
Options to Purchase Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		434	499	14,287
Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	1,668	47,789	4,972	8,362
Unvested PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	540		2,115

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income - Schedule of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from accumulated other comprehensive loss to earnings	$ 0	$ 53	$ (1)	$ 182
Tax (expense) benefit	0	(14)	0	(46)
Net of tax	0	39	(1)	136
Gains (Losses) on available-for-sale securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from accumulated other comprehensive loss to earnings	$ 0	$ 53	$ (1)	$ 182

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income - Schedule of Component of Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 29, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 24, 2023	Jun. 25, 2023	Mar. 26, 2023	Sep. 29, 2024	Sep. 24, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrealized net holding gain, Before Tax	$ 138			$ 271			$ 416	$ 916
Unrealized net holding gain, Tax	(34)			(71)			(102)	(230)
Unrealized net holding gain, After Tax	104			200			314	686
Amounts reclassified from accumulated other comprehensive loss to earnings	0			53			(1)	182
Amounts reclassified for realized losses to earnings	0			(14)			0	(46)
Net of tax	0			39			(1)	136
Other Comprehensive Income (Loss), Tax, Total	(34)			(85)			(102)	(276)
Other comprehensive income, net of tax	104	$ 101	$ 108	239	$ 162	$ 421	313	822
Other comprehensive income, before tax	138			324			415	1,098
Available-for-Sale Debt Securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from accumulated other comprehensive loss to earnings	$ 0			$ 53			$ (1)	$ 182

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) $ in Thousands	9 Months Ended
	Sep. 29, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Long-term supply contracts costs	$ 200,000
Contract cost paid	9,400
Contract cost payable	$ 1,800

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - Sandpebble Builders Preconstruction, Inc - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Sep. 24, 2023	Sep. 29, 2024	Sep. 24, 2023
Related Party Transaction [Line Items]
Expense paid to related party	$ 213	$ 158	$ 753	$ 413
Amounts owed to related party	$ 122	$ 347	$ 122	$ 347